SG Americas Securities’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-50,400
Closed -$187K 3442
2021
Q1
$187K Buy
+50,400
New +$4.25M ﹤0.01% 2715

Other funds holding HZNP

SG Americas Securities's HZNP Position: Q4 2023 in Review

SG Americas Securities sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 43,613 shares — an estimated $5.05M sold.

SG Americas Securities first reported a position in HZNP in Q2 2013 and held it in 37 quarters. The position peaked at $5.05M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • SG Americas Securities reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • SG Americas Securities sold 43,613 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $5.05M.
  • SG Americas Securities first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 37 quarters.
  • SG Americas Securities's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $5.05M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on SG Americas Securities's 13F filing for Q4 2023, filed 12 Jan 2024.